Can Neupogen Be Given as an IV Infusion?
Yes, Neupogen (filgrastim) can be administered as an intravenous (IV) infusion, typically over 15 to 30 minutes for certain indications like chemotherapy-induced neutropenia.[1]
Standard Administration Methods
Neupogen is approved for subcutaneous injection or IV infusion via a short infusion (15-30 minutes) or continuous infusion (up to 24 hours). Subcutaneous is most common for outpatient use, while IV suits hospital settings.[1][2]
When Is IV Infusion Used?
IV infusion is recommended post-myeloablative chemotherapy or for bone marrow transplant patients needing rapid neutrophil recovery. Continuous IV over 24 hours may apply in specific transplant protocols.[1]
Dosage for IV Infusion
For adults post-chemotherapy: 5 mcg/kg/day as a 15-30 minute IV infusion or continuous over 24 hours, adjusted by neutrophil count. Pediatric doses are weight-based similarly.[1]
Differences from Subcutaneous Injection
IV achieves faster peak levels but requires venous access. Subcutaneous is self-administrable at home with slower absorption. Both routes are equally effective for most uses.[2]
Safety and Precautions for IV Use
Dilute in 5% Dextrose only; avoid saline to prevent aggregation. Monitor for infusion reactions like fever or rash. Not for intramuscular use.[1]
[1]: Neupogen Prescribing Information (FDA)
[2]: Drugs.com - Neupogen Administration